Boehringer Ingelheim Pharma Gmbh & Co Kg

Boehringer Ingelheim International Gmbh

Hermann Schollenberger

Kurt Schromm

Ingo Konetzki

Thierry Bouyssou

Andreas Schnapp

Sabine Pestel

Frank Buettner

Claudia Heine

Klaus Rudolf

Christoph Hoenke

Philipp Lustenberger

A pharmaceutical composition comprising a compound of formula 1 wherein:

Medicaments for the treatment of chronic obstructive pulmonary disease

The present invention relates to the use of the compounds of general formula 1 wherein the groups R, X and Y may have the meanings given in the claims and in the specification, for preparing a pharmaceutical composition for the treatment of COPD (chronic obstructive pulmonary disease), as well as new compounds of general formula 1 and processes for preparing them.

3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases

A compound of formula 1 wherein the groups R, R, R, and Rmay have the meanings given in the claims and in the specification, processes for preparing them, and their use as pharmaceutical compositions, particularly for the treatment of inflammatory and obstructive respiratory complaints.

Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals

A compound of formula 1wherein: Ris C-C-alkyl; Ris C-C-alkyl; and Ris C-C-alkyl or phenyl, each optionally mono- or polysubstituted, or Rand Rtogether are &#x2014;CH&#x2014;CH&#x2014; or &#x2014;CH&#x2014;CH&#x2014;CH&#x2014;, or the corresponding acid addition salt with a pharmacologically acceptable acid, processes for preparing such compounds, pharmaceutical compositions containing such compounds, and their use in the treatment of inflammatory and obstructive respiratory diseases.

Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions

Growing community of inventors

Ingelheim am Rhein, Germany

Hermann Schollenberger